Sangamo Therapeutics, Inc.SGMONASDAQ
LOADING
|||
Switch Symbol:
Cash Generation Expanding
Trending higher, above historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-67.41M
↑ 27% above average
Average (9y)
$-92.49M
Historical baseline
Range
High:$155.16M
Low:$-256.53M
CAGR
+7.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-67.41M | +72.6% |
| 2023 | $-246.00M | -0.9% |
| 2022 | $-243.80M | +5.0% |
| 2021 | $-256.53M | -265.3% |
| 2020 | $155.16M | +194.0% |
| 2019 | $-165.08M | -2691.8% |
| 2018 | $-5.91M | -179.6% |
| 2017 | $7.43M | +111.2% |
| 2016 | $-66.61M | -84.4% |
| 2015 | $-36.13M | - |